Bausch Health Companies Inc traded at 10.14 this Friday November 18th, increasing 0.02 or 0.20 percent since the previous trading session. Looking back, over the last four weeks, Bausch Health Companies Inc gained 16.15 percent. Over the last 12 months, its price fell by 69.17 percent. Looking ahead, we forecast Bausch Health Companies Inc to be priced at 9.86 by the end of this quarter and at 9.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
10.14
Daily Change
0.20%
Yearly
-69.17%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Aurora Cannabis Inc 1.79 -0.14 -7.25% -79.82%
Amgen 287.29 -0.01 -0.004% 39.41%
ANI Pharmaceuticals 39.56 -0.13 -0.33% -9.14%
Biogen 302.89 0.84 0.28% 17.77%
Bristol-Myers Squibb 77.45 0.29 0.38% 33.93%
Corcept Therapeutics 26.51 0.54 2.08% 15.92%
Catalent 43.04 0.97 2.31% -66.14%
Danaher 260.65 1.03 0.40% -17.02%
Endo International 0.10 -0.001 -0.91% -98.42%
Gilead Sciences 83.62 0 0% 21.74%
Horizon Pharma 76.26 1.14 1.52% -28.86%
Jazz Pharmaceuticals 147.18 2.06 1.42% 14.65%
Lannett 0.60 0.09 18.22% -67.31%
Eli Lilly 361.67 0.90 0.25% 38.73%
Nektar Therapeutics 3.49 0.06 1.75% -70.42%
Phibro Animal Health 12.48 -0.12 -0.95% -42.73%
Prestige Brands 59.75 1.31 2.24% 2.56%
Pacira 49.04 1.54 3.24% -11.97%
Perrigo 31.86 -0.30 -0.93% -22.56%
Drreddys Laboratories 53.95 -0.67 -1.23% -13.46%
Revance Therapeutics 22.62 0.65 2.96% 64.51%
Supernus Pharmaceuticals 34.53 0.45 1.32% 3.17%
Vertex Pharmaceuticals 314.63 4.73 1.53% 72.04%
Bausch Health Companies Inc 10.14 0.02 0.20% -69.17%
Canopy Growth Corp 4.96 -0.51 -9.32% -67.81%
Zoetis 145.64 2.04 1.42% -35.68%

Indexes Price Day Year
CATSX 19981 96.33 0.48% -7.30%

Bausch Health Companies Inc
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.